4.7 Review

LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond

Journal

Publisher

BMC
DOI: 10.1186/s13046-022-02319-z

Keywords

lncRNA; DNA methylation; Non-coding RNA; DNMT; TET; Cancer

Categories

Funding

  1. National Natural Science Foundation of China [32000426, 31971335]
  2. National Key R&D Program of China [2021YFC2009302]
  3. Special Funds for Transformation and Upgrading of Industrial Informatization of Industry and Information Technology Department of Jiangsu in 2020 [XLYC1802007]
  4. Department of Education of Liaoning Province [1911520092]
  5. Xingliao Talents Program [XLYC1802007]

Ask authors/readers for more resources

DNA methylation is a crucial epigenetic mechanism that regulates gene expression, and aberrant patterns of DNA methylation are associated with human diseases such as cancer. This review provides an overview of the current understanding of long non-coding RNA (lncRNA)-mediated DNA methylation, with a focus on its roles in cancer. The potential clinical applications of this mechanism in RNA-targeting drug development are also discussed.
DNA methylation is one of the most important epigenetic mechanisms to regulate gene expression, which is highly dynamic during development and specifically maintained in somatic cells. Aberrant DNA methylation patterns are strongly associated with human diseases including cancer. How are the cell-specific DNA methylation patterns established or disturbed is a pivotal question in developmental biology and cancer epigenetics. Currently, compelling evidence has emerged that long non-coding RNA (lncRNA) mediates DNA methylation in both physiological and pathological conditions. In this review, we provide an overview of the current understanding of lncRNA-mediated DNA methylation, with emphasis on the roles of this mechanism in cancer, which to the best of our knowledge, has not been systematically summarized. In addition, we also discuss the potential clinical applications of this mechanism in RNA-targeting drug development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents

Bin Sun, Shuai Song, Chen-Zhou Hao, Wan-Xu Huang, Chun-Chi Liu, Hong-Lei Xie, Bin Lin, Mao-Sheng Cheng, Dong-Mei Zhao

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2015)

Article Chemistry, Multidisciplinary

Structure-based virtual screening and ADME/T-based profiling for low molecular weight chemical starting points as p21-activated kinase 4 inhibitors

Ruijuan Li, Xiaolin Su, Zheng Chen, Wanxu Huang, Yali Wang, Kaibo Wang, Bin Lin, Jian Wang, Maosheng Cheng

RSC ADVANCES (2015)

Article Chemistry, Organic

Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion

Chenzhou Hao, Xiaodong Li, Shuai Song, Bingyu Guo, Jing Guo, Jian Zhang, Qiaoling Zhang, Wanxu Huang, Jian Wang, Bin Lin, Maosheng Cheng, Feng Li, Dongmei Zhao

ORGANIC & BIOMOLECULAR CHEMISTRY (2016)

Article Chemistry, Medicinal

Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy

Chenzhou Hao, Wanxu Huang, Xiaodong Li, Jing Guo, Meng Chen, Zizheng Yan, Kai Wang, Xiaolin Jiang, Shuai Song, Jian Wang, Dongmei Zhao, Feng Li, Maosheng Cheng

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Structure-Based Design of 6-Chloro-4-aminoquinazoline-2-carboxamide Derivatives as Potent and Selective p21-Activated Kinase 4 (PAK4) Inhibitors

Chenzhou Hao, Fan Zhao, Hongyan Song, Jing Guo, Xiaodong Li, Xiaolin Jiang, Ran Huan, Shuai Song, Qiaoling Zhang, Ruifeng Wang, Kai Wang, Yu Pang, Tongchao Liu, Tianqi Lu, Wanxu Huang, Jian Wang, Bin Lin, Zhonggui He, Haitao Li, Feng Li, Dongmei Zhao, Maosheng Cheng

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Biochemical Research Methods

Evaluation of the combination mode of azoles antifungal inhibitors with CACYP51 and the influence of Site-directed mutation

Bin Sun, Wanxu Huang, Min Liu

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)

Article Biochemical Research Methods

Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors

Bin Sun, Wanxu Huang, Min Liu, Kang Lei

JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)

Article Chemistry, Medicinal

Computational Insight into p21-Activated Kinase 4 Inhibition: A Combined Ligand- and Structure- Based Approach

Rui-Juan Li, Jian Wang, Zhen Xu, Wan-Xu Huang, Jia Li, Sheng-Fei Jin, Dong-Mei Zhao, Mao-Sheng Cheng

CHEMMEDCHEM (2014)

Article Biochemistry & Molecular Biology

Integrative network analysis identifies cell-specific trans regulators of m6A

Sanqi An, Wanxu Huang, Xiang Huang, Yixian Cun, Weisheng Cheng, Xiang Sun, Zhijun Ren, Yaxin Chen, Wenfang Chen, Jinkai Wang

NUCLEIC ACIDS RESEARCH (2020)

Review Oncology

Roles of METTL3 in cancer: mechanisms and therapeutic targeting

Chengwu Zeng, Wanxu Huang, Yangqiu Li, Hengyou Weng

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Correction Oncology

LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond (vol 41, 100, 2022)

Wanxu Huang, Hua Li, Qingsong Yu, Wei Xiao, Dan Ohtan Wang

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Cell Biology

Crocetin antagonizes parthanatos in ischemic stroke via inhibiting NOX2 and preserving mitochondrial hexokinase-I

Hao Wu, Ying Li, Qian Zhang, Hanxun Wang, Wenyu Xiu, Pu Xu, Yujie Deng, Wanxu Huang, Dan Ohtan Wang

Summary: This study demonstrates that crocetin, a natural antioxidant compound from saffron, antagonizes parthanatos in ischemic stroke. In the early stage of parthanatos, crocetin inhibits the activation of NOX2 to reduce the production of ROS and PAR. In the later stage of parthanatos, crocetin interacts with HK-I to prevent mitochondrial dysfunction and DNA damage, ultimately preventing irreversible cell death. This study supports the further development of crocetin as a potential drug candidate for preventing and/or treating ischemic stroke.

CELL DEATH & DISEASE (2023)

Article Multidisciplinary Sciences

Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy

Weiyue Ban, Mengchi Sun, Hanwei Huang, Wanxu Huang, Siwei Pan, Pengfei Liu, Bingwu Li, Zhenguo Cheng, Zhonggui He, Funan Liu, Jin Sun

Summary: Bacterial outer membrane vesicles (OMVs)-encapsulating adenovirus (Ad) are engineered for autophagy-cascade-augmented immunotherapy, promoting tumor autophagy and enhancing antitumor immune response by altering the tumor microenvironment.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Discovery of indolin-2-one derivatives as potent PAK4 inhibitors: Structure-activity relationship analysis, biological evaluation and molecular docking study

Jing Guo, Mingyue Zhu, Tianxiao Wu, Chenzhou Hao, Kai Wang, Zizheng Yan, Wanxu Huang, Jian Wang, Dongmei Zhao, Maosheng Cheng

BIOORGANIC & MEDICINAL CHEMISTRY (2017)

No Data Available